salvianolic

Salvianolic refers to a family of water-soluble polyphenolic acids isolated from Salvia miltiorrhiza (danshen) and related species. The best-studied members are salvianolic acid A and salvianolic acid B, with several other salvianolic acids identified in Danshen preparations. These compounds are among the major active constituents of danshen and are often used as markers for standardization in herbal preparations.

Chemically, salvianolic acids are highly polar phenolic acids derived from caffeic acid units, typically formed as oligomers. Salvianolic acid B is usually the most abundant and is noted for strong antioxidant capacity.

In pharmacology, salvianolic acids exhibit antioxidant, anti-inflammatory, and antiplatelet effects in vitro and in vivo. They have been investigated for cardiovascular protection, including protection against ischemia-reperfusion injury, as well as potential neuroprotective and hepatoprotective activities. The mechanisms are thought to involve radical scavenging, modulation of inflammatory mediators, and improvements in microcirculation.

In research and clinical use, salvianolic acids are studied as part of Danshen extracts and as individual constituents. They are subject to quality control due to variability in content among preparations. While preclinical data are supportive, clinical evidence is variable, and salvianolic acids are not universally approved as standalone therapies; Danshen products are used within traditional medicine systems and as complementary therapies in some regions.

Safety and regulation: Danshen and salvianolic acid–containing products can interact with anticoagulants and antiplatelet drugs, increasing bleeding risk. High-dose or poorly standardized extracts may cause adverse effects; use should be guided by qualified practitioners, especially in patients with bleeding disorders or liver disease.